Does myocardial protection work?

Advances in Cardiology
|January 1, 1980
PubMed

Insights

Hypothermia and potassium cardioplegia offer superior protection for ischemic myocardium. Immediate induction of cardioplegia and profound cooling to 10°C enhance myocardial preservation during cardiac surgery.

Area of Science:

  • Cardiovascular Surgery
  • Cardiothoracic Medicine
  • Myocardial Protection Strategies

Background:

  • Ischemic heart disease poses significant challenges during cardiac surgery.
  • Current myocardial protection techniques aim to minimize damage during ischemic periods.
  • Optimizing hypothermia and cardioplegia is crucial for improving surgical outcomes.

Purpose of the Study:

  • To evaluate the efficacy of combined hypothermia and potassium cardioplegia for myocardial protection.
  • To identify key factors influencing the effectiveness of this combined approach.
  • To provide recommendations for optimal myocardial protection strategies during cardiac procedures.

Main Methods:

  • Utilizing profound hypothermia (systemic perfusate at 20°C, cardioplegic infusate at 4-10°C).
  • Employing immediate induction of potassium cardioplegia (15-40 mEq/l) upon onset of ischemia.
  • Maintaining cardiac hypothermia via crushed ice or cold electrolyte solution irrigation.
  • Comparing outcomes with varying durations of ischemia and potassium reinfusion protocols.

Main Results:

  • Combined hypothermia and potassium cardioplegia demonstrate enhanced myocardial protection compared to other methods.
  • Profound cooling to 10°C or lower significantly improves myocardial preservation.
  • Immediate cardioplegia induction effectively abolishes contractile activity and conserves energy.
  • Whole blood as a cardioplegic vehicle offers advantages over asanguinous solutions.
  • Safe ischemia durations are defined, with reinfusion protocols established for longer procedures.

Conclusions:

  • Hypothermia combined with potassium cardioplegia represents an effective strategy for myocardial protection.
  • Optimal myocardial protection involves immediate cardioplegia, profound cooling, and appropriate potassium concentrations.
  • Further research may refine the ideal composition of cardioplegic vehicles and precise potassium concentrations.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...